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Identity 
Other names: H2A.X; H2A/X; H2AX; H2a/x 
HGNC (Hugo): H2AFX 
Location: 11q23.3 
Local order: According to NCBI Map Viewer, genes 
from centromere to telomere direction with respect to 
H2AFX, on 11q23 are: hypoxia up-regulated 1 
(HYOU1), vacuolar protein sorting 11 homolog (S. 
cerevisiae) (VPS11), hydroxyl-methylbilane synthase 
(HMBS), H2A histone family, member X (H2AFX), 
dolichyl-phosphate (UDP-N-acetylglucosamine) N-
acetylglucosaminephosphotransferase 1 (GlcNAc-1-P 
transferase) (DPAGT1), transmembrane protein 24 
(TMEM 24), MBD2-interacting zinc finger  
(MIZF). 
Note 
Histone H2AX is a variant of histone H2A and it 
constitutes ~ 15-20% of total histone H2A pool. It 
differs from H2A in the presence of evolutionary 
conserved C-terminal tail that gets phosphorylated at 
serine 140 residue in response to genomic insult and 
also in response to certain stress (heat, hypoxia and 
changes in osmolarity). 
DNA/RNA 
Note 
H2AFX gene sequence is highly GC rich and lies in the 
CpG island (118470228-11847164) with a ratio of 
observed to expected CpG 1.02. 
 
Figure 1: Gene Structure of H2AFX. 
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Figure 2: Protein Structure of histone H2AX protein. 
 
Description 
According to Entrez-Gene, H2AFX gene maps to NC 
000011.8 in the region between 118469794 and 
118471387 on the minus strand. It is a small gene 
(DQ015918) having a single exon of 432 nucleo-tides, 
73 bp 5'UTR and 1089 bp 3'UTR. It contains no 
introns. 
H2AFX is recognized as an important DNA damage 
response (DDR) gene. It maps to cyto-genetic locus 
11q23.2-23.3 that is highly represent-ted among those 
commonly deleted or translocated in several 
haematological malignancies or solid tumors. 
Interestingly other key DNA damage response genes i 
the region are ATM, MRE11 and CHK1; combined 
loss of which can be detrimental to the cell. 
Transcription 
Histone H2AFX mRNA (NM_002105) has 1594 bp 
and is synthesized in G1 as well as S phase. It is known 
to have two forms of transcript; one having a polyA tail 
(1651 bp) and another having a conserved stem-loop 
and U7 binding sequences involved in the processing 
and stability of replica-tion type histone mRNAs (575 
bp). 
Pseudogene 
No pseudogene for H2AFX is known. 
Protein 
Note 
The C-terminal tail of H2AX is highly conserved along 
with the SQ-motif that gets phosphorylated at the serine 
residue by members of phosphoinositide 3-kinase 
related protein kinases (PIKKs). 
Description 
A single exon having a length of 432 nucleotides codes 
for H2AX protein of molecular weight 15 kDA. It has  
characteristic histone H2A domain ranging from 18 to 
91 amino acid with H2A signature motif from 22-28 aa.
The SQ-motif (140-141) is a feature of H2AX variant 
that differentiates it from rest of the members of H2A 
family. The H2AX protein undergoes several 
posttranslational modifications either in constitutive 
manner like monoubiquitination at lysine 120 or in 
response to cellular stress/DNA damage, like 
acetylation of lysine 5 and phosphorylation of serin  
140 and tyrosine 143 residues. By virtue of these 
posttranslational events, H2AX acquires new 
regulatory functions during DNA repair and other 
metabolic processes. 
Expression 
H2AX is ubiquitously expressed in humans with the 
highest levels observed in the proliferating tissue, eg., 
testis and thymus. Phosphorylated H2AX is widely 
correlated with the extent of DNA damage and forms 
discrete nuclear foci at the sites of damage. 
Localisation 
Located in the nucleus and forms discrete foci upon 
DNA damage. 
The figure 3 shows typical staining of H2AX and 
gamma H2AX in HeLa cells before and after the 
treatment with etoposide (10mM). 
Function 
Phosphorylation of Ser-140 (known as gamma-H2AX) 
is critical during DNA double-strand break signaling. 
Apart from the exogeneous agents (radiation and 
chemicals), DSBs generated during replication fork 
stalling, meiotic recombination events and during 
immunoglobulin class switching in lymphocytes are 
also known to induce the formation of gamma H2AX. 
This phosphorylation event can extend up to 1 
megabase on either side of DSB, amplifying the 
damage signal and hence facilitating recruitment of 
repair proteins and accomplishment of repair process. 
The kinases responsible for the serine phosphorylation 
are ATM, ATR and DNA-PKcs. Once the repair is 
complete, dephosphorylation of Ser-140 is mediated by 
a phosphatase, PP2A. 
During meiosis, programmed DSBs are formed in SPO-
11 dependent manner and H2AX-Ser-140 
phosphorylation has been shown to accumulate at 
synaptonemal complexes. With the progression from 
leptotene to zygotene and pachytene, the  










gamma H2AX is subsequently seen sequestered at 
unsynapsed regions of autosomes and also in the XY-
body, probably required for meiotic sex chromosome 
inactivation. (MSCI). 
Apart from ser-140 phosphorylation, the protein also 
gets modified at lysine 5 residue by TIP60 mediated 
acetylation and subsequent ubiquitination by UBC-13 
in response to DNA damage. The functional 
implication of this modification is not very clear 
although it is suggested that this helps in chromatin 
modulation during the repair process. 
Tyrosine 143 phosphorylation of H2AX by WSTF 
having a tyrosine kinase activity and a component of 
WICH ATP-dependent chromatin remodeling complex 
was recently shown to be critical during DNA damage 
response and acts as a switch to apoptosis/cell survival. 
No mutation in H2AFX gene has been detected so far. 
Few direct studies on human cancers, one on 101 
familial breast cancer samples, another on 112 tumors 
from seven different B cell leukemia/ lymphoma and 
yet another on sporadic breast cancer patients failed to 
identify any change at nucleotide level. A partial 
deletion of the region encompassing H2AFX was 
however identified in significant proportion of head 
and neck squamous cell carcinoma. 
Homology 
The sequence of 22 residues at carboxy terminal of 
H2AX is unique and is unrelated to any of the H2A 
family member but is highly conserved and is present 
in all eukaryotes. 
Mutations 
Note 





Histone H2AX has been implicated in different human 
cancers based on association studies of polymorphisms 
found in the promoter region of the gene. SNPs in the 
far promoter region of H2AFX (rs643788, rs8551 and 
rs7759, rs2509049) has been shown to be associated 
with the risk of sporadic breast cancer and Non-
Hodgkin's Lymphomas but no association was 
observed in case of bladder carcinoma. Also alteration 
of H2AFX gene copy number in significant proportion 
(37%) of sporadic breast cancer patients has been 
reported. 
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